In controlled clinical trials, the most frequent adverse experiences reported for Dovonex® (calcipotriene cream) Cream, 0.005% were cases of skin irritation, which occurred in approximately 10-15% of patients.
Section
Not stated
Context
Reported in approximately 10-15% of patients in controlled clinical trials.